The First End-to-End AI-Designed Drug Has Phase 2 Data. What Rentosertib’s Results Mean for the Pipeline.

AI-designed drug phase 2

This analysis looks at the latest AI-designed drug phase 2 evidence and what it means for development timelines. A 118.7 mL separation in forced vital capacity between treatment and placebo. Twelve weeks. Seventy-one patients. That is the data point the AI drug discovery field has been waiting for, and it arrived in June 2025 when … Read more